These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16715123)

  • 1. Grateloupia longifolia polysaccharide inhibits angiogenesis by downregulating tissue factor expression in HMEC-1 endothelial cells.
    Zhang C; Yang F; Zhang XW; Wang SC; Li MH; Lin LP; Ding J
    Br J Pharmacol; 2006 Jul; 148(6):741-51. PubMed ID: 16715123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidic mucopolysaccharide from Holothuria leucospilota has antitumor effect by inhibiting angiogenesis and tumor cell invasion in vivo and in vitro.
    Zhang W; Lu Y; Xu B; Wu J; Zhang L; Gao M; Zheng S; Wang A; Zhang C; Chen L; Lei N
    Cancer Biol Ther; 2009 Aug; 8(15):1489-99. PubMed ID: 19483477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.
    Pan SL; Guh JH; Peng CY; Wang SW; Chang YL; Cheng FC; Chang JH; Kuo SC; Lee FY; Teng CM
    J Pharmacol Exp Ther; 2005 Jul; 314(1):35-42. PubMed ID: 15784655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
    Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
    Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
    Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
    Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
    Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
    Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
    Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.
    Xu HY; Pan YM; Chen ZW; Lin Y; Wang LH; Chen YH; Jie TT; Lu YY; Liu JC
    J Ethnopharmacol; 2013 Apr; 146(3):724-33. PubMed ID: 23434607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo.
    Niu YC; Liu JC; Zhao XM; Wu XX
    Oncol Rep; 2009 Jan; 21(1):145-52. PubMed ID: 19082455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic effects of GFP08, an agaran-type polysaccharide isolated from Grateloupia filicina.
    Yu Q; Yan J; Wang S; Ji L; Ding K; Vella C; Wang Z; Hu Z
    Glycobiology; 2012 Oct; 22(10):1343-52. PubMed ID: 22707571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on antiangiogenesis effect of Vaccaria segetalis].
    Feng L; Hua H; Qiu LY; Zhang LF; Jin J
    Zhong Yao Cai; 2009 Aug; 32(8):1256-9. PubMed ID: 19960951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo study of hydralazine, a potential anti-angiogenic agent.
    Zhang Q; Lin Z; Yin X; Tang L; Luo H; Li H; Zhang Y; Luo W
    Eur J Pharmacol; 2016 May; 779():138-46. PubMed ID: 26968484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.
    Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY
    Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.